Published on
January 4, 2024
- 22:53 GMT
Rejuvenation Technologies and Kudo Biotechnology agree to develop one of Rejuvenation’s RNA drug candidates
Rejuvenation Technologies and Kudo Biotechnology agree to develop one of Rejuvenation’s RNA drug candidates NEEDHAM, MASSACHUSETTS, UNITED STATES, January 4, 2024 /EINPresswire.com/ -- Rejuvenation Technologies and Kudo Biotechnology have entered into …
Distribution channels:
Companies, Media, Advertising & PR
...